The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)

NCT00887315 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Slow accrual and loss of sponsor

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Docetaxel and cisplatin
RADIATION: Docetaxel and cisplatin Plus Hypofractionated Radiotherapy

Sponsor

University of Chicago